Publications in collaboration with researchers from Novartis (Sweden) (1)

2013

  1. Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: Results of the randomized IMPRES study

    Circulation, Vol. 127, Núm. 10, pp. 1128-1138